Mean ± SD | |
---|---|
N | 47 |
Sex (M/F) | 23/24 |
Age at rhGH onset (year) | 9.8 ± 1.8 |
Tanner stage (stage 0/stage 1) | 36/11 |
Mean rhGH dose (µg/kg day) | 70.8 ± 19 |
Treatment duration (months) | 18.1 ± 7.3 |
Growth rate before treatment (cm/year) | 4.6 ± 1.0 |
Growth rate during treatment (cm/year) | 9.1 ± 1.5 |
Plasma IGF1 at baseline (ng/ml) | 167 ± 80 |
Mean IGF1during treatment (ng/ml) | 402 ± 123 |
Delta IGF1 under treatment (ng/ml) | 235 ± 117 |